Venture Capital Investment | Plutus Investment Group
About Us
A team of industry experts with a successful investment experience
Our Philosophy
Investing in Tomorrow’s Champions
Founded in 2021 by a seasoned group of entrepreneurs, investors and industry veterans, Plutus Investment Group is a family office that focuses on backing startups in Europe and the USA.
We’re looking for leaders with a drive and a strong vision. While we only invest in a handful of companies a year, it means we can provide the time, the energy and the capital for those companies to succeed and become a game changers
About
Our Management Team
Our team combined investment experience exceeds 60 years
MOHAMMED JAMAL
Founder – Chief Executive Officer
Bio
Mr Jamal has over 18 years of experience in structuring, placement, trading, private equity and liquid Investing. Mr Jamal started his career at Morgan Stanley in the structured credit team in 2003. In 2009 Mr Jamal moved to Resource America a $15Bn credit fund to lead their business in Europe.
In 2012 Mr Jamal founded Molton Street Capital a London based CLO, CDO and ABS trading company that traded over $3Bn.
In 2016 Mr Jamal co-founded Forepont Capital Group, a leading life science Venture Capital fund with office in London, New York and Paris
Mr Jamal invested in more than 20 companies since 2012 and made multiple successful exits.
Mr Jamal holds a Masters degree in Applied Mathematics and Computer Sciences from Ecole Centrale Paris (top French “ Grande Ecole” ) and an advanced degree (DEA) in Finance and Economics from La Sorbonne University in Paris.
STEVE WEATHERHEAD
Chief Operating Officer
( Non-Executive )
Bio
Mr Weatherhead started in structured finance in 1995 in Australia. Mr Weatherhead joined Ambac in 2000 providing financial guarantees to a broad range of European securitisation issuance. In 2003 Mr Weatherhead joined Morgan Stanley to run corporate securitisation, and became the European Head of Credit for the bank’s principal investment business. Since leaving Morgan Stanley, Mr Weatherhead has held senior positions in securitisation, structuring and reinsurance at insurance companies L&G and Aviva.
Mr Weatherhead has also been a non-executive credit committee member of the AE Global Investment Solutions credit fund since 2014
DR CLAIRE BUTTON
Bio
Doctor Claire holds a BSc in medical Biochemistry From king’s college London and a PhD in Immunopharmacology from the University Of Liverpool. As an investor, board member, and company CEO, Dr Claire is a leader at executive levels. She has been appointed as the head of healthtech investments as Director of wealth management firm, and has been actively investing globally with Family Offices and Sovereign Wealth Funds. Dr Claire is also a Member of medtech committee for VC fund and is an angel investor in techbio ventures. Her previous CEO roles included restructuring and leading a neurotech business across Nordic countries, Japan, and UK,raising funds, pivoting strategy, forming partnerships, and building teams. Dr Claire is also a presenter, mentor and judge for accelerator programmes, including KQ Labs, BIA Pulse, MedCity and Wellcome Trust.
The Geniuses Behind Our Work
Board Members
We have an outstanding Board Of Directors with an extended expertise in key industries
MOHAMMED JAMAL
Chief Executive Officer ( London )
Bio
Mr Jamal has over 18 years of experience in structuring, placement, trading, private equity and liquid Investing.
Mr Jamal started his career at Morgan Stanley in the structured credit team in 2003. In 2009 Mr Jamal moved to Resource America a $15Bn credit fund to lead their business in Europe.
In 2012 Mr Jamal founded Molton Street Capital a London based CLO, CDO and ABS trading company that traded over $3Bn.
In 2016 Mr Jamal co-founded Forepont Capital Group, a leading life science Venture Capital fund with office in London, New York and Paris
Mr Jamal invested in more than 20 companies since 2012 and made multiple successful exits.
Mr Jamal holds a Masters degree in Applied Mathematics and Computer Sciences from Ecole Centrale Paris (top French “ Grande Ecole” ) and an advanced degree (DEA) in Finance and Economics from La Sorbonne University in Paris.
STEVE WEATHERHEAD
Chief Operating Officer (London)
Bio
Mr Weatherhead started in structured finance in 1995 in Australia. Mr Weatherhead joined Ambac in 2000 providing financial guarantees to a broad range of European securitisation issuance.
In 2003 Mr Weatherhead joined Morgan Stanley to run corporate securitisation, and became the European Head of Credit for the bank’s principal investment business.
Since leaving Morgan Stanley, Mr Weatherhead has held senior positions in securitisation, structuring and reinsurance at insurance companies L&G and Aviva.
Mr Weatherhead has also been a non-executive credit committee member of the AE Global Investment Solutions credit fund since 2014
DR MICHELLE TEMPEST
Venture Partner – Life Science (London)
Bio
Dr Tempest is partner in a strategic management consultancy company, Candesic, with global clients ranging from investors to large operators in specialist sectors – life sciences, healthcare, social care, digital and education .
She was a hospital doctor for over a decade and still teaches medical students at Cambridge University.
She’s author of a book about technology and the human brain – ‘Big Brain Revolution: Artificial Intelligence – Spy or Saviour’, a best seller on Amazon for AI in 2020.
She is an angel investor and chairs the EU advisory board for Citadel, a global Laboratory and diagnostics information system.
She is an MD from Cambridge University
DR CLAIRE BUTTON
Bio
Doctor Claire holds a BSc in medical Biochemistry From king’s college London and a PhD in Immunopharmacology from the University Of Liverpool. As an investor, board member, and company CEO, Dr Claire is a leader at executive levels. She has been appointed as the head of healthtech investments as Director of wealth management firm, and has been actively investing globally with Family Offices and Sovereign Wealth Funds. Dr Claire is also a Member of medtech committee for VC fund and is an angel investor in techbio ventures. Her previous CEO roles included restructuring and leading a neurotech business across Nordic countries, Japan, and UK,raising funds, pivoting strategy, forming partnerships, and building teams. Dr Claire is also a presenter, mentor and judge for accelerator programmes, including KQ Labs, BIA Pulse, MedCity and Wellcome Trust.
NADIR-BENOIT ELBIED
Venture Partner – Credit & Fintech (New York)
Bio
Mr. Elbied has close to 20 years of capital markets experience, holding senior roles across both banking and trading with extensive experience analyzing, structuring, negotiating, and distributing complex financial instruments across a diverse range of asset classes.
Mr. Elbied founded Mont Blanc Capital Partners (“MBCP”) in May 2016 to invest opportunistically in illiquid and/or special situations through private debt or equity.
Mr. Elbied started his career at Greenwich Capital Markets (an affiliate of the Royal Bank of Scotland) in 1999, where he was a core member of the Structured Products Group.
In 2010, he was appointed head trader of a team tasked with the orderly disposition of a $100bn+ global portfolio of non-core assets comprised of financial instruments and direct investments.
Mr Elbied received a diplome d’ingenieur in Applied Mathematics and Computer Science from ENSIMAG (France) and graduated with a MSc in Financial Mathematics from the University of Chicago.
Mr Elbied has been a CFA charterholder since 2004.
Youssef Boujemaoui
Head of partnership and member of the board
Bio
Youssef Boujemaoui holds a Master of Science from Telecom Paris and an Advanced Master’s degree in mathematical methods and modelling from University Paris 1 – Pantheon Sorbonne in 2004. He started his career in the financial industry in 2003 where he held several key roles in Top tier Investment banks covering quantitative finance, trading, structuring and equity financing. Joining IXIS CIB in Paris in 2004 to run their trading activities in the Financial, Retail and consumer goods, Youssef was part of the team closing an Employee Stock Options Program in 2006, a 500 million euros Trade helping the distribution of Stock options to employees worldwide. In 2006, he moved to London to join Dresdner Kleinwort Investment Bank and run their quantitative strategies trading within Equity derivatives. In 2009, he was an advisor to the CEO of BCP Bank, the largest investment bank in Morocco headquartered in Casablanca where he was a member of the investment committee and in charge of new products development including International Trading and Securitisation. It was in 2010 that he joined Bank of America in the Equities division, he was the Managing Director in charge of the Structured products and Strategic Equity Trading based in London and covering teams in EMEA and APAC. Prior to this position, he traded the Macro and Wealth Management portfolio. During his time at Bank of America, Youssef closed several key strategic deals in the auto, financial, tobacco, pharmaceutical and insurance sector including a $10 billion Equity collar financing, he also run the share buyback program for several European companies in the retail, aerospace and insurance sector. BofA was awarded the Derivatives house of the year in 2020. In 2021, Youssef left BofA to become an independent advisor and investor, he is a member of the board of companies operating in Venture Capital, Capital markets and Asset management. Youssef is also a certified life coach since 2021.
Member Name
Member Position
Member Description
ISSAM EL MOUHTADI
Venture Partner
Bio
M. El Mouhtadi has started his career in London in 2005 at Goldman Sachs as a research analyst covering the European banking sector before becoming an entrepreneur in 2010 in Morocco & UAE. He founded and successfully built several companies throughout the years in the distribution, chemicals and special civil engineering technology, with innovation and technology being at the core of each endeavor. M. El Mouhtadi brings in an extensive network across the MENA region and with his hands-on approach he has developed a strong expertise around business structuring, value creation, technical know-how and business development that brings a bottom-up and a value creation expertise to Plutus investments. Furthermore, M. El Mouhtadi brings in an extensive network across the MENA region.
M. El Mouhtadi holds a Masters degree in Science of Management (Msc.), with a major in Finance from EM Lyon Business School (Top French. “Grande Ecole”).
